首页 > 最新文献

European Urology Open Science最新文献

英文 中文
Super-resolution ultrasound imaging of the prostate, near-microscopic representation of normal and abnormal tissue 前列腺的超分辨率超声成像,近显微镜下正常和异常组织的表现
IF 4.5 3区 医学 Q1 UROLOGY & NEPHROLOGY Pub Date : 2025-12-01 DOI: 10.1016/S2666-1683(25)02523-6
McNeill A., Gallagher K.G, Butler M., Papageorgiou G., Mobberley A., Grigorescu R., Keanie J., Good D., O’Donnell M., Leslie N., Lu W., Sboros V.
{"title":"Super-resolution ultrasound imaging of the prostate, near-microscopic representation of normal and abnormal tissue","authors":"McNeill A., Gallagher K.G, Butler M., Papageorgiou G., Mobberley A., Grigorescu R., Keanie J., Good D., O’Donnell M., Leslie N., Lu W., Sboros V.","doi":"10.1016/S2666-1683(25)02523-6","DOIUrl":"10.1016/S2666-1683(25)02523-6","url":null,"abstract":"","PeriodicalId":12254,"journal":{"name":"European Urology Open Science","volume":"82 ","pages":"Page S29"},"PeriodicalIF":4.5,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145839235","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Continuous quality improvement in TURBT: Experience from one centre with 45 years of prospectively collected data turt的持续质量改进:来自一个中心45年前瞻性收集数据的经验
IF 4.5 3区 医学 Q1 UROLOGY & NEPHROLOGY Pub Date : 2025-12-01 DOI: 10.1016/S2666-1683(25)02516-9
Mariappan P., Hart-Brooke J., Smith G.
{"title":"Continuous quality improvement in TURBT: Experience from one centre with 45 years of prospectively collected data","authors":"Mariappan P., Hart-Brooke J., Smith G.","doi":"10.1016/S2666-1683(25)02516-9","DOIUrl":"10.1016/S2666-1683(25)02516-9","url":null,"abstract":"","PeriodicalId":12254,"journal":{"name":"European Urology Open Science","volume":"82 ","pages":"Pages S20-S21"},"PeriodicalIF":4.5,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145836417","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The prognostic role of immunosuppressive tumour microenvironment biomarkers in renal cell cancer with venous tumour thrombus 免疫抑制肿瘤微环境生物标志物在肾细胞癌伴静脉肿瘤血栓中的预后作用
IF 4.5 3区 医学 Q1 UROLOGY & NEPHROLOGY Pub Date : 2025-12-01 DOI: 10.1016/S2666-1683(25)02522-4
Zapala L.P., Kunc M., Sharma S., Pęksa R., Popęda M., Radziszewski P.
{"title":"The prognostic role of immunosuppressive tumour microenvironment biomarkers in renal cell cancer with venous tumour thrombus","authors":"Zapala L.P., Kunc M., Sharma S., Pęksa R., Popęda M., Radziszewski P.","doi":"10.1016/S2666-1683(25)02522-4","DOIUrl":"10.1016/S2666-1683(25)02522-4","url":null,"abstract":"","PeriodicalId":12254,"journal":{"name":"European Urology Open Science","volume":"82 ","pages":"Page S28"},"PeriodicalIF":4.5,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145839237","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Quality of surgery as a significant predictor of post-operative oncological and functional outcomes in patients submitted to radical prostatectomy: A video-based analysis 手术质量作为根治性前列腺切除术患者术后肿瘤和功能预后的重要预测因素:一项基于视频的分析
IF 4.5 3区 医学 Q1 UROLOGY & NEPHROLOGY Pub Date : 2025-12-01 DOI: 10.1016/S2666-1683(25)02527-3
Suardi N.R., Nocera L., Furlan M.C., Mirabella G., Lonati C., Zamboni S., Ambrosini F., Mantica G., Terrone C.
{"title":"Quality of surgery as a significant predictor of post-operative oncological and functional outcomes in patients submitted to radical prostatectomy: A video-based analysis","authors":"Suardi N.R., Nocera L., Furlan M.C., Mirabella G., Lonati C., Zamboni S., Ambrosini F., Mantica G., Terrone C.","doi":"10.1016/S2666-1683(25)02527-3","DOIUrl":"10.1016/S2666-1683(25)02527-3","url":null,"abstract":"","PeriodicalId":12254,"journal":{"name":"European Urology Open Science","volume":"82 ","pages":"Page S33"},"PeriodicalIF":4.5,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145839765","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Urorectal fistula repair after local treatment for prostate cancer: Long-term follow-up and patient-reported experience measures 前列腺癌局部治疗后尿直肠瘘修复:长期随访和患者报告的经验措施
IF 4.5 3区 医学 Q1 UROLOGY & NEPHROLOGY Pub Date : 2025-12-01 DOI: 10.1016/S2666-1683(25)02512-1
Wagner M.C., Klemm J., Filipas D.K., Schulz R.J., Roessler N., Fisch M., Dahlem R., Vetterlein M.W.
{"title":"Urorectal fistula repair after local treatment for prostate cancer: Long-term follow-up and patient-reported experience measures","authors":"Wagner M.C., Klemm J., Filipas D.K., Schulz R.J., Roessler N., Fisch M., Dahlem R., Vetterlein M.W.","doi":"10.1016/S2666-1683(25)02512-1","DOIUrl":"10.1016/S2666-1683(25)02512-1","url":null,"abstract":"","PeriodicalId":12254,"journal":{"name":"European Urology Open Science","volume":"82 ","pages":"Pages S14-S15"},"PeriodicalIF":4.5,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145839767","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Copyright page 版权页
IF 4.5 3区 医学 Q1 UROLOGY & NEPHROLOGY Pub Date : 2025-12-01 DOI: 10.1016/S2666-1683(25)02466-8
{"title":"Copyright page","authors":"","doi":"10.1016/S2666-1683(25)02466-8","DOIUrl":"10.1016/S2666-1683(25)02466-8","url":null,"abstract":"","PeriodicalId":12254,"journal":{"name":"European Urology Open Science","volume":"82 ","pages":"Page I"},"PeriodicalIF":4.5,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145786491","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The use of surgical AI in urology anno 2025 2025年泌尿外科手术人工智能的应用
IF 4.5 3区 医学 Q1 UROLOGY & NEPHROLOGY Pub Date : 2025-12-01 DOI: 10.1016/S2666-1683(25)02504-2
Mottrie A.
{"title":"The use of surgical AI in urology anno 2025","authors":"Mottrie A.","doi":"10.1016/S2666-1683(25)02504-2","DOIUrl":"10.1016/S2666-1683(25)02504-2","url":null,"abstract":"","PeriodicalId":12254,"journal":{"name":"European Urology Open Science","volume":"82 ","pages":"Page S5"},"PeriodicalIF":4.5,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145836354","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A simplified modification of the lateral approach in nerve-sparing robotic radical prostatectomy: Technical description and early experience 保留神经的机器人根治性前列腺切除术中外侧入路的简化改进:技术描述和早期经验
IF 4.5 3区 医学 Q1 UROLOGY & NEPHROLOGY Pub Date : 2025-12-01 DOI: 10.1016/S2666-1683(25)02524-8
Grivas N., Zabaftis C., Nikitakis F., Tsela S., Leotsakos I., Katafigiotis I., Karavitakis M.
{"title":"A simplified modification of the lateral approach in nerve-sparing robotic radical prostatectomy: Technical description and early experience","authors":"Grivas N., Zabaftis C., Nikitakis F., Tsela S., Leotsakos I., Katafigiotis I., Karavitakis M.","doi":"10.1016/S2666-1683(25)02524-8","DOIUrl":"10.1016/S2666-1683(25)02524-8","url":null,"abstract":"","PeriodicalId":12254,"journal":{"name":"European Urology Open Science","volume":"82 ","pages":"Page S30"},"PeriodicalIF":4.5,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145839154","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
25-year update of an artificial intelligence based (AIUSP) prospective prostate clinical monitoring trail: 1999-2025 基于人工智能(AIUSP)的前瞻性前列腺临床监测试验的25年更新:1999-2025
IF 4.5 3区 医学 Q1 UROLOGY & NEPHROLOGY Pub Date : 2025-12-01 DOI: 10.1016/S2666-1683(25)02506-6
Loch T.
{"title":"25-year update of an artificial intelligence based (AIUSP) prospective prostate clinical monitoring trail: 1999-2025","authors":"Loch T.","doi":"10.1016/S2666-1683(25)02506-6","DOIUrl":"10.1016/S2666-1683(25)02506-6","url":null,"abstract":"","PeriodicalId":12254,"journal":{"name":"European Urology Open Science","volume":"82 ","pages":"Pages S7-S8"},"PeriodicalIF":4.5,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145839238","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Impact of H1 Antihistamines on Bacillus Calmette-Guérin–treated Non–muscle-invasive Bladder Cancer H1抗组胺药对卡介苗-谷氨酰胺治疗非肌肉浸润性膀胱癌的影响
IF 4.5 3区 医学 Q1 UROLOGY & NEPHROLOGY Pub Date : 2025-11-25 DOI: 10.1016/j.euros.2025.11.001
Kang Liu , Alex Qinyang Liu , Hongda Zhao , Chris Ho-Ming Wong , Peter Ka-Fung Chiu , Chi-Fai Ng , Jeremy Yuen-Chun Teoh

Background and objective

Concomitant H1 antihistamine (H1-AH) administration is associated with better survival outcomes for patients with metastatic urothelial carcinoma receiving immunotherapy. However, the role of H1-AHs among patients with non–muscle-invasive bladder cancer (NMIBC) treated with adjuvant intravesical bacillus Calmette-Guérin (BCG) immunotherapy has not been explored. Our aim was to investigate the impact of H1-AH use on survival outcomes for patients with BCG-treated NMIBC.

Methods

We conducted a territory-wide retrospective observational study. Patients with NMIBC who received intravesical immunotherapy with a single BCG strain in Hong Kong from 2001 to 2020 were identified. H1-AH prescription data were recorded. Overall survival (OS), cancer-specific survival (CSS), recurrence-free survival (RFS), and progression-free survival (PFS) outcomes were compared between H1-AH and control groups using the Kaplan-Meier method and multivariable Cox regression.

Key findings and limitations

Our analysis included 2028 patients with NMIBC who received intravesical BCG immunotherapy. Of these, 1539 patients (76%) had a H1-AH prescription at baseline and 489 (24%) never received any H1-AH prescription during the study period. Median follow-up was 11.0 yr. Kaplan-Meier analysis revealed that the H1-AH group had better CSS (p = 0.017) and PFS (p = 0.001). Subgroup analysis by H1-AH timing (before or during BCG therapy) showed that concomitant H1-AH treatment during intravesical BCG immunotherapy was associated with better CSS (p = 0.002) and PFS (p = 0.005). Multivariable Cox regression results demonstrated that concomitant H1-AH treatment was associated with better OS (hazard ratio [HR] 0.69, 95% confidence interval [CI] 0.58–0.82), CSS (HR 0.44, 95% CI 0.30–0.65), RFS (HR 0.81, 95% CI 0.67–0.98), and PFS (HR 0.64, 95% CI 0.45–0.91).

Conclusions and clinical implications

Concomitant H1-AH treatment was associated with better OS, CSS, RFS, and PFS for patients with NMIBC receiving adjuvant intravesical BCG.

Patient summary

The treatment for non–muscle-invasive bladder cancer (NMIBC) typically includes a solution of BCG (bacillus Calmette-Guérin) instilled into the bladder. We found better survival outcomes (overall survival, cancer-specific survival, recurrence-free survival, and progression-free survival) for patients who took a H1 antihistamine during their BCG treatment for intermediate-risk or high-risk NMIBC. More research is needed to confirm our results.
背景与目的:在接受免疫治疗的转移性尿路上皮癌患者中,同时给予H1抗组胺药(H1- ah)与更好的生存结果相关。然而,H1-AHs在接受辅助膀胱内卡介苗免疫治疗的非肌浸润性膀胱癌(NMIBC)患者中的作用尚未探讨。我们的目的是研究H1-AH使用对bcg治疗的NMIBC患者生存结果的影响。方法采用全地区回顾性观察性研究。从2001年到2020年,香港的NMIBC患者接受了单一卡介苗株的膀胱免疫治疗。记录H1-AH处方数据。采用Kaplan-Meier法和多变量Cox回归比较H1-AH组和对照组的总生存期(OS)、癌症特异性生存期(CSS)、无复发生存期(RFS)和无进展生存期(PFS)。sour分析包括2028例接受膀胱内卡介苗免疫治疗的NMIBC患者。其中,1539名患者(76%)在基线时服用过H1-AH处方,489名患者(24%)在研究期间从未服用过任何H1-AH处方。中位随访时间为11.0年。Kaplan-Meier分析显示,H1-AH组有更好的CSS (p = 0.017)和PFS (p = 0.001)。根据H1-AH时间(卡介苗治疗前或治疗期间)进行的亚组分析显示,膀胱内卡介苗免疫治疗期间同时进行H1-AH治疗与更好的CSS (p = 0.002)和PFS (p = 0.005)相关。多变量Cox回归结果显示,合并H1-AH治疗与更好的OS(风险比[HR] 0.69, 95%可信区间[CI] 0.58-0.82)、CSS (HR 0.44, 95% CI 0.30-0.65)、RFS (HR 0.81, 95% CI 0.67-0.98)和PFS (HR 0.64, 95% CI 0.45-0.91)相关。结论和临床意义:对于接受辅助膀胱内卡介苗治疗的NMIBC患者,伴随H1-AH治疗与更好的OS、CSS、RFS和PFS相关。非肌肉侵袭性膀胱癌(NMIBC)的治疗通常包括将卡介苗(卡介苗芽孢杆菌)溶液灌注到膀胱中。我们发现,在治疗中危或高危NMIBC期间服用H1抗组胺药的患者有更好的生存结果(总生存期、癌症特异性生存期、无复发生存期和无进展生存期)。需要更多的研究来证实我们的结果。
{"title":"Impact of H1 Antihistamines on Bacillus Calmette-Guérin–treated Non–muscle-invasive Bladder Cancer","authors":"Kang Liu ,&nbsp;Alex Qinyang Liu ,&nbsp;Hongda Zhao ,&nbsp;Chris Ho-Ming Wong ,&nbsp;Peter Ka-Fung Chiu ,&nbsp;Chi-Fai Ng ,&nbsp;Jeremy Yuen-Chun Teoh","doi":"10.1016/j.euros.2025.11.001","DOIUrl":"10.1016/j.euros.2025.11.001","url":null,"abstract":"<div><h3>Background and objective</h3><div>Concomitant H1 antihistamine (H1-AH) administration is associated with better survival outcomes for patients with metastatic urothelial carcinoma receiving immunotherapy. However, the role of H1-AHs among patients with non–muscle-invasive bladder cancer (NMIBC) treated with adjuvant intravesical bacillus Calmette-Guérin (BCG) immunotherapy has not been explored. Our aim was to investigate the impact of H1-AH use on survival outcomes for patients with BCG-treated NMIBC.</div></div><div><h3>Methods</h3><div>We conducted a territory-wide retrospective observational study. Patients with NMIBC who received intravesical immunotherapy with a single BCG strain in Hong Kong from 2001 to 2020 were identified. H1-AH prescription data were recorded. Overall survival (OS), cancer-specific survival (CSS), recurrence-free survival (RFS), and progression-free survival (PFS) outcomes were compared between H1-AH and control groups using the Kaplan-Meier method and multivariable Cox regression.</div></div><div><h3>Key findings and limitations</h3><div>Our analysis included 2028 patients with NMIBC who received intravesical BCG immunotherapy. Of these, 1539 patients (76%) had a H1-AH prescription at baseline and 489 (24%) never received any H1-AH prescription during the study period. Median follow-up was 11.0 yr. Kaplan-Meier analysis revealed that the H1-AH group had better CSS (<em>p</em> = 0.017) and PFS (<em>p</em> = 0.001). Subgroup analysis by H1-AH timing (before or during BCG therapy) showed that concomitant H1-AH treatment during intravesical BCG immunotherapy was associated with better CSS (<em>p</em> = 0.002) and PFS (<em>p</em> = 0.005). Multivariable Cox regression results demonstrated that concomitant H1-AH treatment was associated with better OS (hazard ratio [HR] 0.69, 95% confidence interval [CI] 0.58–0.82), CSS (HR 0.44, 95% CI 0.30–0.65), RFS (HR 0.81, 95% CI 0.67–0.98), and PFS (HR 0.64, 95% CI 0.45–0.91).</div></div><div><h3>Conclusions and clinical implications</h3><div>Concomitant H1-AH treatment was associated with better OS, CSS, RFS, and PFS for patients with NMIBC receiving adjuvant intravesical BCG.</div></div><div><h3>Patient summary</h3><div>The treatment for non–muscle-invasive bladder cancer (NMIBC) typically includes a solution of BCG (bacillus Calmette-Guérin) instilled into the bladder. We found better survival outcomes (overall survival, cancer-specific survival, recurrence-free survival, and progression-free survival) for patients who took a H1 antihistamine during their BCG treatment for intermediate-risk or high-risk NMIBC. More research is needed to confirm our results.</div></div>","PeriodicalId":12254,"journal":{"name":"European Urology Open Science","volume":"83 ","pages":"Pages 23-29"},"PeriodicalIF":4.5,"publicationDate":"2025-11-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145616056","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
European Urology Open Science
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1